Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aussie Scientists Report First Vaccine For Rheumatic Fever

This article was originally published in PharmAsia News

Executive Summary

Australian researchers report creating the first vaccine for rheumatic fever, with human trials expected to begin next year. The Queensland Institute of Medical Research scientists said animal studies have shown the vaccine to be effective in blocking the disease, caused by the streptococcus A bacteria also responsible for strep throat and rheumatic heart disease. Australia has the largest rates of rheumatic fever and heart disease infections. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071636

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel